GlassScriptPhysician profile
Ravi Shankar
NPI 1235387259
$1,017.78
in general payments reported to CMS, 2019-2025
20 companies · $17.13 in 2025
The $17.13 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $865 · 2020: $40.02 · 2021: $58.85 · 2023: $37.10 · 2025: $17.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $54.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $54.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $191.72 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $125.00 | 2019 | |
| Genentech USA, INC. | $109.91 | 2019 | |
| Amgen INC. | $95.36 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $81.35 | 2019 | |
| Celgene Corporation | $45.73 | 2019 | |
| Emd Serono, INC. | $45.47 | 2019 | |
| Beigene USA, INC. | $37.10 | 2023 | Brukinsa |
| Merck Sharp & Dohme LLC | $36.50 | 2019 | |
| Puma Biotechnology, INC. | $35.96 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.59 | 2019 | |
| Genzyme Corporation | $32.27 | 2019 | |
| Clovis Oncology, INC. | $22.84 | 2019 | |
| Janssen Biotech, INC. | $19.99 | 2019 | |
| Alexion Pharmaceuticals, INC. | $19.90 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $19.76 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.43 | 2019 | |
| Abbvie INC. | $17.13 | 2025 | |
| Seagen INC. | $16.50 | 2019 | |
| Rigel Pharmaceuticals, INC. | $13.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Shankar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.